Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass"

NCT: NCT05921643 · RECRUITING

NCT IDNCT05921643
StatusRECRUITING
Start Date2023-09-29
Completion2030-04
SponsorCentre Hospitalier Intercommunal Creteil (OTHER)
First posted
Last updated

Brief Summary

Adult patients referred to the ENT surgery department of the Hospices Civils de Lyon with cholesteatoma that had never been operated on. All patients will benefit from surgical management for cholesteatoma initially in the operating room under general anesthesia. The surgical technique (closed technique) is the reference technique for the management of cholesteatoma in adults. It involves a cartilaginous removal to reconstruct the attical region. Then a filling material is used to fill the mastoid (GlassBONE™ or Bonalive™), and above all to stabilize the cartilaginous fragment to prevent a recurrence.

Frequently Asked Questions

What is Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass"?

Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass" is a clinical trial registered under NCT05921643. Current status: RECRUITING.

What is the status of NCT05921643?

The current status of NCT05921643 (Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass") is: RECRUITING.

When did Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass" start?

Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass" started on 2023-09-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.